These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39389877)

  • 1. Analysis of Risk Factors for Kasabach Merritt Phenomenom in Children With Kaposiform Hemangioendothelioma.
    Chen C; Yan H; Yao W; Wang Z; Li K
    J Pediatr Surg; 2024 Sep; ():161932. PubMed ID: 39389877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of age and tumor size on the development of the Kasabach-Merritt phenomenon in patients with kaposiform hemangioendothelioma: a retrospective cohort study.
    Zhou J; Lan Y; Qiu T; Gong X; Zhang Z; He C; Peng Q; Hu F; Zhang X; Lu G; Qiu L; Kong F; Zhang Y; Chen S; Ji Y
    Precis Clin Med; 2023 Jun; 6(2):pbad008. PubMed ID: 37305527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals.
    Croteau SE; Liang MG; Kozakewich HP; Alomari AI; Fishman SJ; Mulliken JB; Trenor CC
    J Pediatr; 2013 Jan; 162(1):142-7. PubMed ID: 22871490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
    Ji Y; Yang K; Peng S; Chen S; Xiang B; Xu Z; Li Y; Wang Q; Wang C; Xia C; Li L; Liu X; Lu G; Yang G; Wu H
    Br J Dermatol; 2018 Aug; 179(2):457-463. PubMed ID: 29603128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonography and magnetic resonance imaging features of kaposiform hemangioendothelioma and tufted angioma.
    Gong X; Ying H; Zhang Z; Wang L; Li J; Ding A; Zhou L; Lin X; Xiong P
    J Dermatol; 2019 Oct; 46(10):835-842. PubMed ID: 31373042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment experience for different risk groups of Kaposiform hemangioendothelioma.
    Li M; Wang X; Kieran R; Sun ZW; Gong Y; Lei H; Sun B; Xiao L; Wang Y; Wang S; Li Z; Wang L; Lv R; Xue F; Ge J; Dong C; Huo R
    Front Oncol; 2024; 14():1336763. PubMed ID: 38903724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphedema in patients with kaposiform hemangioendothelioma: incidence, clinical features, risk factors and management.
    Ji Y; Chen S; Xia C; Zhou J; Jiang X; Xu X; Yang K; Zhang X; Kong F; Lu G; Zhang Y
    Orphanet J Rare Dis; 2020 Nov; 15(1):313. PubMed ID: 33160383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposiform haemangioendothelioma: ultrasonographic features and risk factors for the Kasabach-Merritt phenomenon.
    Zhao J; Yuan JJ; Dong CX; Zhang X; Li C; Sun Q; Wu G
    Ultraschall Med; 2024 Oct; ():. PubMed ID: 39406368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon.
    Vivas-Colmenares GV; Ramirez-Villar GL; Bernabeu-Wittel J; Matute de Cardenas JA; Fernandez-Pineda I
    Dermatol Pract Concept; 2015 Jan; 5(1):91-3. PubMed ID: 25692091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
    Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
    Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
    Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
    Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Musculoskeletal complication in kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: clinical characteristics and management.
    Ji Y; Yang K; Chen S; Peng S; Lu G; Liu X
    Cancer Manag Res; 2018; 10():3325-3331. PubMed ID: 30233248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and imaging features of Kaposiform Hemangioendothelioma.
    Hu PA; Zhou ZR
    Br J Radiol; 2018 Jun; 91(1086):20170798. PubMed ID: 29536769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
    Brill R; Uller W; Huf V; Müller-Wille R; Schmid I; Pohl A; Häberle B; Perkowski S; Funke K; Till AM; Lauten M; Neumann J; Güttel C; Heid E; Ziermann F; Schmid A; Hüsemann D; Meyer L; Sporns PB; Schinner R; Schmidt VF; Ricke J; Rössler J; Kapp FG; Wohlgemuth WA; Wildgruber M
    Int J Cancer; 2021 May; 148(9):2345-2351. PubMed ID: 33231291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
    Schmid I; Klenk AK; Sparber-Sauer M; Koscielniak E; Maxwell R; Häberle B
    World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
    Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kasabach-Merritt Phenomenon: Classic Presentation and Management Options.
    Mahajan P; Margolin J; Iacobas I
    Clin Med Insights Blood Disord; 2017; 10():1179545X17699849. PubMed ID: 28579853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y; Chen S; Yang K; Xia C; Peng S
    J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-Related Quality of Life in Children With Kaposiform Hemangioendothelioma.
    Dai S; Yang K; Qiu T; Zhou J; Zhang X; Chen S; Li L; Ji Y
    Front Pediatr; 2022; 10():720611. PubMed ID: 35281237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: Experience of a rare case of rebound of the Kasabach-Merritt phenomenon during sirolimus treatment in kaposiform hemangioendothelioma.
    Wang L; Li J; Wu C; Song D; Liu Z; Niu Y; Zhou J; Guo L
    Front Pediatr; 2022; 10():949950. PubMed ID: 35990005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.